Vanguard Investments Australia’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$162M Buy
1,263,127
+24,973
+2% +$2.92M 0.4% 37
2026
Q1
$149M Buy
+1,238,154
New +$143M 0.43% 35

Other funds holding MRK

Vanguard Investments Australia's MRK Position: Q2 2026 in Review

Vanguard Investments Australia increased its Merck (MRK) stake by 2% in Q2 2026, buying an estimated $2.92M and bringing the position to 1,263,127 shares worth $162M. The position accounts for 0.4% of the portfolio, ranked #37.

Vanguard Investments Australia first reported a position in MRK in Q1 2026 and has held it in 2 quarters since. 3,688 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Vanguard Investments Australia held 1,263,127 shares of Merck worth $162M as of Q2 2026.
  • Vanguard Investments Australia bought 24,973 Merck shares in Q2 2026, an estimated $2.92M.
  • Merck made up 0.4% of Vanguard Investments Australia's portfolio in Q2 2026, its #37 holding.
  • Vanguard Investments Australia first reported a position in Merck in Q1 2026 and has held it in 2 quarters since.
  • 3,688 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.